Monocytes in neonatal stroke and hypoxic-ischemic encephalopathy: Pathophysiological mechanisms and therapeutic

Pedro M Pimentel-Coelho1

  • 1Carlos Chagas Filho Biophysics Institute Federal University of Rio de Janeiro Rio de Janeiro Brazil.

Neuroprotection (Chichester, England)
|December 12, 2025
PubMed

Insights

Neonatal stroke and hypoxic-ischemic encephalopathy involve immune cell infiltration into the brain. Understanding monocyte roles in these conditions is crucial for developing new infant neurological treatments.

Area of Science:

  • Neuroscience
  • Immunology
  • Neonatal Medicine

Background:

  • Neonatal arterial ischemic stroke (NAIS) and neonatal hypoxic-ischemic encephalopathy (HIE) are significant causes of infant neurological deficits with limited treatments.
  • These conditions trigger innate immune responses, recruiting peripheral immune cells like monocytes to the brain.
  • The dual role of monocytes/monocyte-derived cells in neuroinflammation and brain repair in NAIS and HIE is not fully understood.

Purpose of the Study:

  • To comprehensively review monocyte infiltration mechanisms and functions in the ischemic brain, specifically in NAIS and HIE.
  • To explore the potential long-term consequences of persistent monocyte-derived macrophages in the neonatal brain.
  • To discuss therapeutic strategies targeting monocytes and their potential for cell-based therapies.

Main Methods:

  • Literature review focusing on monocyte infiltration and function in neonatal stroke and HIE.
  • Analysis of current evidence regarding immune cell recruitment and persistence in the neonatal brain.
  • Synthesis of information on therapeutic approaches and cell-based therapy potential.

Main Results:

  • Monocyte infiltration is a key feature of the innate immune response in NAIS and HIE.
  • Monocytes and derived macrophages may play complex roles in both damaging neuroinflammation and beneficial brain repair.
  • Evidence suggests monocyte-derived macrophages can persist long-term in the brain post-insult, with unknown consequences.

Conclusions:

  • Further research is needed to elucidate the precise roles of monocytes in neonatal ischemic brain injury.
  • Targeting monocyte pathways presents a potential therapeutic avenue for NAIS and HIE.
  • Monocyte-based cell therapies warrant investigation for treating neonatal neurological impairments.

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...